Enanta Pharmaceuticals
ENTA
#7362
Rank
A$0.66 B
Marketcap
A$23.17
Share price
5.92%
Change (1 day)
127.39%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.42 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are A$0.42 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-09-30A$0.54 B-24.27%
2023-09-30A$0.71 B23.22%
2022-09-30A$0.58 B-3.81%
2021-09-30A$0.60 B-10.55%
2020-09-30A$0.67 B-6.48%
2019-09-30A$0.72 B26.5%
2018-09-30A$0.57 B37.73%
2017-09-30A$0.41 B13.05%
2016-09-30A$0.36 B4.94%
2015-09-30A$0.35 B97.3%
2014-09-30A$0.17 B41.73%
2013-09-30A$0.12 B149.15%
2012-09-30A$50.37 M88.04%
2011-09-30A$26.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AbbVie
ABBV
A$201.54 B 47,596.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$290.22 B 68,583.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$37.42 B 8,756.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$194.99 B 46,045.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.83 B 34,412.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$161.49 B 38,117.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland